"Some 85% of surgeons polled by Admedus stated they would use CardioCel 3D immediately, and the first human use of the product is anticipated for this June" (from announcement)
---------------------------------
I would imagine this first use of the product will be well publicized and filmed to show the medical world and hopefully change the minds of those 15% of surgeons who didn't say they'd use it.
Can someone tell me what sort of number of operations could require CardioCel 3D per year?
Just trying to get an idea of total value to the company per year.
Not just good for the company's bottom line but also great for the patients.
Regards
Dabru
Ann: Admedus Receives FDA Clearance for CardioCel 3D, page-45
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.99 |
Change
-0.910(8.35%) |
Mkt cap ! $211.1M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.79 | $9.30 | $1.477M | 149.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $9.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.99 | 1999 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |